Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122716163> ?p ?o ?g. }
- W2122716163 endingPage "1377" @default.
- W2122716163 startingPage "1366" @default.
- W2122716163 abstract "ABSTRACT Fluconazole in vitro susceptibility test results for 256,882 isolates of Candida spp. were collected from 142 sites in 41 countries from June 1997 to December 2007. Data were collected for 197,619 isolates tested with voriconazole from 2001 to 2007. A total of 31 different species of Candida were isolated. Increased rates of isolation of the common non- albicans species C. glabrata (10.2% to 11.7%), C. tropicalis (5.4% to 8.0%), and C. parapsilosis (4.8% to 5.6%) were noted when the time periods 1997 to 2000 and 2005 to 2007 were compared. Investigators tested clinical isolates of Candida spp. by the CLSI M44-A disk diffusion method. Overall, 90.2% of Candida isolates tested were susceptible (S) to fluconazole; however, 13 of 31 species identified exhibited decreased susceptibility (<75% S), similar to that seen with the resistant (R) species C. glabrata and C. krusei . Among 197,619 isolates of Candida spp. tested against voriconazole, 95.0% were S and 3% were R. About 30% of fluconazole-R isolates of C. albicans , C. glabrata , C. tropicalis , C. rugosa , C. lipolytica , C. pelliculosa , C. apicola , C. haemulonii , C. humicola , C. lambica , and C. ciferrii remained S to voriconazole. An increase in fluconazole resistance over time was seen with C. parapsilosis , C. guilliermondii , C. lusitaniae , C. sake , and C. pelliculosa . Among the emerging fluconazole-R species were C. guilliermondii (11.4% R), C. inconspicua (53.2% R), C. rugosa (41.8% R), and C. norvegensis (40.7% R). The rates of isolation of C. rugosa , C. inconspicua , and C. norvegensis increased by 5- to 10-fold over the 10.5-year study period. C. guilliermondii and C. rugosa were most prominent in Latin America, whereas C. inconspicua and C. norvegensis were most common in Eastern European countries. This survey identifies several less-common species of Candida with decreased susceptibility to azoles. These organisms may pose a future threat to optimal antifungal therapy and underscore the importance of prompt and accurate species identification and antifungal susceptibility testing." @default.
- W2122716163 created "2016-06-24" @default.
- W2122716163 creator A5014043395 @default.
- W2122716163 creator A5028081249 @default.
- W2122716163 creator A5039929555 @default.
- W2122716163 creator A5046372032 @default.
- W2122716163 creator A5046599212 @default.
- W2122716163 creator A5051134148 @default.
- W2122716163 creator A5058664659 @default.
- W2122716163 creator A5079734791 @default.
- W2122716163 creator A5091620517 @default.
- W2122716163 date "2010-04-01" @default.
- W2122716163 modified "2023-10-10" @default.
- W2122716163 title "Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of <i>Candida</i> Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion" @default.
- W2122716163 cites W1530201273 @default.
- W2122716163 cites W1564109607 @default.
- W2122716163 cites W1955515831 @default.
- W2122716163 cites W1966690773 @default.
- W2122716163 cites W1968950826 @default.
- W2122716163 cites W1978554068 @default.
- W2122716163 cites W1979497376 @default.
- W2122716163 cites W1980078612 @default.
- W2122716163 cites W1998374422 @default.
- W2122716163 cites W2014904057 @default.
- W2122716163 cites W2017248809 @default.
- W2122716163 cites W2023209852 @default.
- W2122716163 cites W2026807900 @default.
- W2122716163 cites W2030456354 @default.
- W2122716163 cites W2040491977 @default.
- W2122716163 cites W2042376233 @default.
- W2122716163 cites W2046034819 @default.
- W2122716163 cites W2048635739 @default.
- W2122716163 cites W2061567342 @default.
- W2122716163 cites W2074527518 @default.
- W2122716163 cites W2076094587 @default.
- W2122716163 cites W2084643045 @default.
- W2122716163 cites W2096176564 @default.
- W2122716163 cites W2096246633 @default.
- W2122716163 cites W2096852486 @default.
- W2122716163 cites W2097026648 @default.
- W2122716163 cites W2099241550 @default.
- W2122716163 cites W2102828908 @default.
- W2122716163 cites W2105978586 @default.
- W2122716163 cites W2108831297 @default.
- W2122716163 cites W2109959458 @default.
- W2122716163 cites W2110209578 @default.
- W2122716163 cites W2113623235 @default.
- W2122716163 cites W2120210280 @default.
- W2122716163 cites W2120834638 @default.
- W2122716163 cites W2124750674 @default.
- W2122716163 cites W2126246398 @default.
- W2122716163 cites W2126303105 @default.
- W2122716163 cites W2127319074 @default.
- W2122716163 cites W2127333071 @default.
- W2122716163 cites W2130347060 @default.
- W2122716163 cites W2130634937 @default.
- W2122716163 cites W2132582794 @default.
- W2122716163 cites W2134402113 @default.
- W2122716163 cites W2134794454 @default.
- W2122716163 cites W2135021455 @default.
- W2122716163 cites W2136619689 @default.
- W2122716163 cites W2138433856 @default.
- W2122716163 cites W2138947616 @default.
- W2122716163 cites W2139809581 @default.
- W2122716163 cites W2141563676 @default.
- W2122716163 cites W2143443625 @default.
- W2122716163 cites W2144983535 @default.
- W2122716163 cites W2145047464 @default.
- W2122716163 cites W2145295807 @default.
- W2122716163 cites W2147418284 @default.
- W2122716163 cites W2149716740 @default.
- W2122716163 cites W2150382742 @default.
- W2122716163 cites W2150428940 @default.
- W2122716163 cites W2155895327 @default.
- W2122716163 cites W2158046793 @default.
- W2122716163 cites W2160721469 @default.
- W2122716163 cites W2165223360 @default.
- W2122716163 cites W2167143090 @default.
- W2122716163 cites W2169735925 @default.
- W2122716163 cites W2171510971 @default.
- W2122716163 cites W2275269550 @default.
- W2122716163 cites W4238261271 @default.
- W2122716163 doi "https://doi.org/10.1128/jcm.02117-09" @default.
- W2122716163 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2849609" @default.
- W2122716163 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20164282" @default.
- W2122716163 hasPublicationYear "2010" @default.
- W2122716163 type Work @default.
- W2122716163 sameAs 2122716163 @default.
- W2122716163 citedByCount "536" @default.
- W2122716163 countsByYear W21227161632012 @default.
- W2122716163 countsByYear W21227161632013 @default.
- W2122716163 countsByYear W21227161632014 @default.
- W2122716163 countsByYear W21227161632015 @default.
- W2122716163 countsByYear W21227161632016 @default.
- W2122716163 countsByYear W21227161632017 @default.
- W2122716163 countsByYear W21227161632018 @default.
- W2122716163 countsByYear W21227161632019 @default.
- W2122716163 countsByYear W21227161632020 @default.